Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
INTERVENTIONAL
2007-08-31
2008-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Validation of Embryo Cinematography
NCT01549262
Embryo Aneuploidies and Ovarian Stimulation
NCT00707525
Comparison of Culture Media for in Vitro Embryo Development
NCT02846012
Does in Vivo Culture of Pre-cleavage Stage Embryo Reduce the Incidence of Aneuploidy?
NCT02652143
Embryo Development in Microfluidics System of Culture
NCT01003548
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
in vivo (ANECOVA D-1) or in vitro culture in 25-µl droplets of cleavage medium (Medicult®) under paraffin oil
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hormonal serum levels within normal ranges (FSH, LH, E2, PRL, P4, T4, TSH)
* Negative serologic screening for HIV, Hep B and C
* No uterine or ovarian alterations found by ultrasound
* Normal BMI (19 - 29 kg/m2).
Exclusion Criteria
* Endometriosis or PCO
* Severe male factor in the partner
18 Years
36 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Anecova SA
INDUSTRY
Instituto Valenciano de Infertilidad, IVI VALENCIA
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Instituto Valenciano de Infertilidad
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin Velasco
Role: STUDY_DIRECTOR
Affiliated
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Instituto Valenciano de Infertilidad Spain
Valencia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Blockeel C, Mock P, Verheyen G, Bouche N, Le Goff P, Heyman Y, Wrenzycki C, Hoffmann K, Niemann H, Haentjens P, de Los Santos MJ, Fernandez-Sanchez M, Velasco M, Aebischer P, Devroey P, Simon C. An in vivo culture system for human embryos using an encapsulation technology: a pilot study. Hum Reprod. 2009 Apr;24(4):790-6. doi: 10.1093/humrep/dep005. Epub 2009 Mar 9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCVD1H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.